Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1993
11/30/1993CA1324763C Treatment of periodontal disease
11/30/1993CA1324762C 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
11/30/1993CA1324761C 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
11/30/1993CA1324760C Treatment of skin with esters of pyroglutamic acid
11/30/1993CA1324759C Topical composition containing an ester of pyroglutamic acid
11/30/1993CA1324758C Transdermal antisecretory agents for gastrointestinal disease
11/30/1993CA1324756C Butylated hydroxyanisoles for the treatment of retro-viral diseases, as retro-virus infectivity modifying agents and as anti-infective products
11/30/1993CA1324755C Preparation for treating immune complex diseases
11/28/1993CA2096998A1 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent
11/28/1993CA2096556A1 Fatty acid treatment
11/27/1993WO1993024460A1 5-aminoquinolonecarboxylic acid derivative and antibacterial containing the same as active ingredient
11/27/1993CA2102196A1 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
11/27/1993CA2096902A1 Ophthalmic compositions containing vitamin e or ester thereof as an active ingredient
11/27/1993CA2096395A1 N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
11/26/1993CA2096804A1 Heterocyclic derivatives, method of preparation thereof and pharmaceutical compositions which contain them
11/25/1993WO1993023572A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
11/25/1993WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993WO1993023555A1 Cultured taxus tissues as a source of taxol, related taxanes and other novel anti-tumor/anti-viral compounds
11/25/1993WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
11/25/1993WO1993023546A1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent
11/25/1993WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
11/25/1993WO1993023420A1 NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023419A1 NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023418A1 Purine derivatives
11/25/1993WO1993023417A1 Novel adenosine derivatives
11/25/1993WO1993023411A1 Compounds based on palladium and on derivatives of aromatic amines and method of obtaining them
11/25/1993WO1993023409A1 Phosphonic diester derivative
11/25/1993WO1993023407A1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them
11/25/1993WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
11/25/1993WO1993023402A1 3-azetidinylthio-carbapeneme derivatives, their preparation and use as antimicrobial agents
11/25/1993WO1993023401A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993WO1993023399A1 6-AMINO SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
11/25/1993WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
11/25/1993WO1993023396A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
11/25/1993WO1993023395A1 Heteroaromatic quinuclidinenes, their use and preparation
11/25/1993WO1993023393A1 Indazol-3-one-2-yl derivatives of benzopyrans
11/25/1993WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993WO1993023389A1 Novel taxane derivatives, their preparation and compositions containing same
11/25/1993WO1993023384A1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials
11/25/1993WO1993023383A1 Gaba and l-glutamic acid analogs for antiseizure treatment
11/25/1993WO1993023380A1 Bridged aza-bicyclic derivatives as substance p antagonists
11/25/1993WO1993023379A1 Retroviral protease inhibitors
11/25/1993WO1993023378A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993WO1993023375A1 Substituted pyridines, their preparation and pharmaceutical use
11/25/1993WO1993023373A1 N-[N'-(5-AMINO-4-HYDROXY-ACYLOYL)-α-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
11/25/1993WO1993023358A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
11/25/1993WO1993023082A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
11/25/1993WO1993023079A1 Method for nonspecific cellular immune stimulation
11/25/1993WO1993023075A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
11/25/1993WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/25/1993WO1993023064A1 Compositions and methods for the prevention and treatment of thrombosis
11/25/1993WO1993023062A1 Therapeutic conjugates of toxins and drugs
11/25/1993WO1993023061A1 Therapeutic uses of pungent botanicals and their related compounds
11/25/1993WO1993023059A1 Use of exogeneous glycosaminoglycanes or derivatives in the treatment of thrombopenias
11/25/1993WO1993023058A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia
11/25/1993WO1993023057A1 Method and reagent for inhibiting cancer development
11/25/1993WO1993023056A1 Preventive or therapeutic agent for infectious diseases containing mizoribine as active ingredient
11/25/1993WO1993023055A1 N-acetyl glucosamine as gastroprotective agent
11/25/1993WO1993023054A1 Polyphosphorylated organic compounds: compositions useful in protecting biological tissues
11/25/1993WO1993023053A1 INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
11/25/1993WO1993023052A1 Use of guanylate cyclase inhibitors in the treatment of shock
11/25/1993WO1993023051A1 New 17-ester, amide, and ketone derivatives of 3-oxo-4-azasteroids as 5a-reductase inhibitors
11/25/1993WO1993023050A1 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023048A1 4-azasteroid 5-alpha-reductase inhibitors
11/25/1993WO1993023047A1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
11/25/1993WO1993023046A1 Enantiomeric cynemicin analogs, preparation and use thereof
11/25/1993WO1993023045A1 Use of cotinine to alleviate tobacco withdrawal syndrome
11/25/1993WO1993023044A1 Treating or preventing ocular inflammation or systemic inflammatory disease
11/25/1993WO1993023043A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/25/1993WO1993023042A1 17α AND 17β SUBSTITUTED ACYL 4 AZA STEROIDS
11/25/1993WO1993023041A1 Ester derivatives of 4-aza-steroids
11/25/1993WO1993023040A1 17-ethers and thioethers of 4-aza-steroids
11/25/1993WO1993023038A1 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023035A2 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
11/25/1993WO1993023034A1 Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy
11/25/1993WO1993023033A1 Apoptosis inducer
11/25/1993WO1993023032A1 Remedy for cataract and production thereof
11/25/1993WO1993023030A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
11/25/1993WO1993023029A1 Antitussive
11/25/1993WO1993023028A1 Dipalmitoylhydroxyproline and oleoylmethionine containing composition
11/25/1993WO1993023027A1 Use of alpha-ketoglutarate
11/25/1993WO1993023026A1 2-arylpropionic acid compositions and process for preparing the same
11/25/1993WO1993023025A1 Transdermal administration of oxybutynin
11/25/1993WO1993023024A1 Diamines in the treatment of arrhythmia
11/25/1993WO1993023023A1 Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
11/25/1993WO1993023022A1 Solid dispersion compositions of tebufelone
11/25/1993WO1993023021A2 Therapeutic combinations
11/25/1993WO1993023020A1 Contraception method using competitive progesterone antagonists and novel compounds useful therein
11/25/1993WO1993023018A1 Compositions in the form of films for the treatment of periodontolysis and fabrication process
11/25/1993WO1993023016A1 Liposomal formulations containing rifamycins
11/25/1993WO1993023014A1 Chemotherapeutic drug combinations
11/25/1993WO1993020810A3 Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
11/25/1993WO1993019720A3 Compounds
11/25/1993WO1993018769A3 A new use of quinazoline derivative
11/25/1993WO1993018764A3 Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993WO1993015103A3 Novel steroid intermediates and processes for their preparation
11/25/1993DE4217039A1 Appts. for iontophoretic application of active agents - comprising electrode, counter electrode, and appts. for supplying current connected to both electrodes
11/25/1993DE4216942A1 Tetrahydro- und Perhydroisochinolin-Derivate und diese enthaltende therapeutische Mittel Tetrahydro- and perhydroisoquinoline derivatives and therapeutic agents containing them
11/25/1993DE4216829A1 Pyridyl derivs. with antithrombotic properties
1 ... 7149 7150 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 7169 ... 7860